Skip to content
  • Sunday, 26 July 2026
  • 2:58 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • UK Approves Lower Dose of Needle-Free Adrenaline Nasal Spray for Young Children
Pharmaceutical R&D

UK Approves Lower Dose of Needle-Free Adrenaline Nasal Spray for Young Children

Teuku Ryan Jun 15, 2026 0

The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for a new, lower dose of ALK-Abelló’s…

Read More
Neuroscience & Brain Research

Texas A&M University Researchers Develop Breakthrough Nasal Spray to Reverse Brain Aging and Combat Neurodegenerative Decline

Rifan Muazin Jun 3, 2026 0

In a significant advancement for regenerative medicine and neurology, a research team at Texas A&M University has unveiled a novel…

Read More
Neuroscience & Brain Research

Texas A&M Researchers Develop Breakthrough Nasal Spray to Reverse Brain Aging and Combat Cognitive Decline

Rifan Muazin May 27, 2026 0

In a significant advancement for regenerative medicine, a team of scientists at Texas A&M University has developed an experimental nasal…

Read More
Biotech & Genetic Research

Groundbreaking Nasal Spray Delivers Therapeutic miRNA to Combat Neuroinflammaging and Age-Related Cognitive Decline

Jia Lissa Apr 21, 2026 0

Researchers at the Texas A&M University Naresh K. Vashisht College of Medicine (TX, USA), under the leadership of Ashok Shetty,…

Read More
Human Skeletal Development Blueprint Reveals New Insights into Arthritis and Congenital Bone ConditionsRay Therapeutics Secures $125 Million Series B Funding to Accelerate Vision Restoration PipelineTWiV 1287: Ancient Herpesviruses and Modern DementiaCitius Oncology Secures Up to $36.5 Million in Debt and Equity Financing to Fuel Lymphir Commercialization
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ